Tracking non-relapse mortality after CAR T cell therapy

被引：0

作者：

Blumenberg, Viktoria ^{[1
,2
]}

Maus, Marcela V. ^{[1
,2
]}

机构：

[1] Massachusetts Gen Hosp, Cellular Immunotherapy Program, Boston, MA 02114 USA

[2] Harvard Med Sch, Boston, MA 02115 USA

来源：

NATURE MEDICINE | 2024年 / 30卷 / 09期

关键词：

LYMPHOMA;

D O I：

10.1038/s41591-024-03212-2

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Infections account for the highest number of non-relapse-related deaths after CAR T cell therapy, underscoring the necessity for clinical risk-mitigating strategies and a deeper understanding of CAR T cell-related cytopenia.

引用

页码：2413 / 2414

页数：2

共 50 条

[1] Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma
Wesson, William
Dima, Danai
Suleman, Nahid
Saif, Md Saiful Islam
Tabak, Carine
Logan, Emerson
Davis, James A.
McGann, Mary
Furqan, Fateeha
Mohan, Meera
Rashid, Aliya
Abdallah, Al-Ola
Ullah, Fauzia
Shune, Leyla
Mushtaq, Muhammad Umair
Raza, Shahzad
McGuirk, Joseph
Hamadani, Mehdi
Anwer, Faiz
Hashmi, Hamza
Ahmed, Nausheen
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (09): : 876 - 884
[2] LOW NON-RELAPSE MORTALITY ASSOCIATED WITH ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION AFTER CAR-T FAILURE IN PATIENTS AFFECTED BY LARGE B CELL LYMPHOMA
de Philippis, Chiara
Gambella, Massimiliano
Mariotti, Jacopo
Dodero, Anna
Chiusolo, Patrizia
Castellino, Alessia
Giordano, Laura
Sarina, Barbara
Taurino, Daniela
Mannina, Daniele
Raiola, Anna Maria
Sica, Simona
Carlo-Stella, Carmelo
Angelucci, Emanuele
Santoro, Armando
Corradini, Paolo
Bramanti, Stefania
BONE MARROW TRANSPLANTATION, 2024, 59 : 479 - 480
[3] Survivorship in Chimeric Antigen Receptor T-Cell Therapy Recipients: Infections, Secondary Malignancies, and Non-Relapse Mortality
Tix, Tobias
Subklewe, Marion
von Bergwelt-Baildon, Michael
Rejeski, Kai
ONCOLOGY RESEARCH AND TREATMENT, 2024,
[4] Prediction of Non-Relapse Mortality with Dynamic Easix Scores after Allogeneic Hematopoietic Cell Transplantation
Nawas, Mariam T.
Sanchez-Escamilla, Miriam
Devlin, Sean M.
Maloy, Molly A.
Perales, Miguel
Giralt, Sergio A.
Scordo, Michael
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S189 - S190
[5] Late non-relapse mortality after allogeneic hematopoietic cell transplantation: the impact of bronchiolitis obliterans
Ozdemir Kumbasar, O
Arat, M
Beksac, M
Ilhan, O
Alper, D
Koc, H
BONE MARROW TRANSPLANTATION, 2002, 29 : S215 - S215
[6] IMPACT OF PATIENT WEIGHT ON NON-RELAPSE MORTALITY AFTER MARROW TRANSPLANTATION
DEEG, HJ
SEIDEL, K
BRUEMMER, B
PEPE, MS
APPELBAUM, FR
BONE MARROW TRANSPLANTATION, 1995, 15 (03) : 461 - 468
[7] Non-relapse mortality associated with autologous stem cell transplant (ASCT)
Stotler, Christy
Kalaycio, Matt
Dean, Robert M.
Sobecks, Ronald
Copelan, Edward A.
Andresen, Steven
Pohlman, Brad
William, John
Rybicki, Sweetenham Lisa
Brown, Stacey
Bell, Kim
Cherni, Kelly
Bernhard, Laura
Ferraro, Christina
Bolwell, Brian J.
BLOOD, 2007, 110 (11) : 498A - 498A
[8] Impact of comorbidity indexes on non-relapse mortality
A Xhaard
R Porcher
J W Chien
R P de Latour
M Robin
P Ribaud
V Rocha
A Devergie
C Ferry
P J Martin
G Socié
Leukemia, 2008, 22 : 2062 - 2069
[9] Impact of comorbidity indexes on non-relapse mortality
Xhaard, A.
Porcher, R.
Chien, J. W.
de Latour, R. P.
Robin, M.
Ribaud, P.
Rocha, V.
Devergie, A.
Ferry, C.
Martin, P. J.
Socie, G.
LEUKEMIA, 2008, 22 (11) : 2062 - 2069
[10] Recipient T-Cell Repertoire Diversity after Double Umbilical Cord Transplantation Correlates with Non-Relapse Mortality and Survival
Nikiforow, Sarah
Kim, Haesook T.
McDonough, Sean M.
Emerson, Ryan
Hamm, David
Ballen, Karen K.
Boussiotis, Vassiliki A.
Soiffer, Robert J.
Antin, Joseph H.
Ritz, Jerome
Cutler, Corey S.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S243 - S244

← 1 2 3 4 5 →